Daily news on healthcare and wellness in Italy

Provided by AGP

Perspectify News

Learn about labels.

Labels
Left-wing Center-left Neutral Public Broadcaster Gov't Institution Center-right Right-wing Pro-Government Gov't Propaganda Indeterminate

Filter

Source Label Filters

All labels are selected. Deselect any labels you want to hide from your feed.

Labels:

Left-wing
Center-left
Neutral
Public Broadcaster
Gov't Institution
Center-right
Right-wing
Pro-Government
Gov't Propaganda
Indeterminate
Angelini Pharma to acquire Catalyst Pharmaceuticals for equity value of $4.1bn

Angelini Pharma to acquire Catalyst Pharmaceuticals for equity value of $4.1bn

Rubio set to meet Italy's Meloni as both sides seek to ease frictions over Iran war

Rubio set to meet Italy's Meloni as both sides seek to ease frictions over Iran war

Dyadic Health Literacy and Its Association with Care Collaboration and Satisfaction in Heart Failure Patient–Caregiver Dyads: A Cross-Sectional Study

Dyadic Health Literacy and Its Association with Care Collaboration and Satisfaction in Heart Failure Patient–Caregiver Dyads: A Cross-Sectional Study

“Giro” Break: Rollout – ASSOS x EF Pro, Tailwind Nutrition, Castelli 150 Years, Wilier Tiestina Rapida, Sungod Velans 2, Fabric Lumaray V3

“Giro” Break: Rollout – ASSOS x EF Pro, Tailwind Nutrition, Castelli 150 Years, Wilier Tiestina Rapida, Sungod Velans 2, Fabric Lumaray V3


Alpha Tau Successfully Treats First Pancreatic Cancer Patient in Italy with Alpha DaRT® at the University of Verona’s Pancreas Institute
May. 7, 2026

Alpha Tau Successfully Treats First Pancreatic Cancer Patient in Italy with Alpha DaRT® at the University of Verona’s Pancreas Institute

GlobeNewswire, Inc.

VCD Medical Appoints Renowned Commercial and Vascular Leader  Denna Babul as General Manager, U.S.
May. 7, 2026

VCD Medical Appoints Renowned Commercial and Vascular Leader Denna Babul as General Manager, U.S.

GlobeNewswire, Inc.

Solid Biosciences Doses First Participant in Phase 3 IMPACT DUCHENNE Clinical Trial Evaluating SGT-003 in Duchenne Muscular Dystrophy
May. 7, 2026

Solid Biosciences Doses First Participant in Phase 3 IMPACT DUCHENNE Clinical Trial Evaluating SGT-003 in Duchenne Muscular Dystrophy

GlobeNewswire, Inc.

Beyond the Base: Soccer Match Unites NSA Naples, Italian Community
May. 7, 2026

Beyond the Base: Soccer Match Unites NSA Naples, Italian Community

DVIDS - Georgia

NewAmsterdam Pharma Provides Corporate Update and Reports First Quarter Financial Results
May. 7, 2026

NewAmsterdam Pharma Provides Corporate Update and Reports First Quarter Financial Results

GlobeNewswire, Inc.

Angelini Pharma to Acquire Catalyst Pharmaceuticals for 4.1 Billion USD (3.5 Billion Euros), Entering the U.S. Market and Consolidating its Leadership in Brain Health and Rare Disease
May. 7, 2026

Angelini Pharma to Acquire Catalyst Pharmaceuticals for 4.1 Billion USD (3.5 Billion Euros), Entering the U.S. Market and Consolidating its Leadership in Brain Health and Rare Disease

GlobeNewswire, Inc.

More

Video Stories

YouTube video thumbnail: Venice Biennale Faces Outcry Over Israel and Russia's Participation
Play
Venice Biennale Faces Outcry Over Israel and Russia's Participation
YouTube video thumbnail: UK Elections: What Does it Mean to Be Scottish Today?
Play
UK Elections: What Does it Mean to Be Scottish Today?
Discover Affinity Group Publishing
YouTube video thumbnail: Zelenskyy Hails 'Important Step' as Hungary Returns Assets Seized From Ukraine Bank Workers
Play
Zelenskyy Hails 'Important Step' as Hungary Returns Assets Seized From Ukraine Bank Workers
YouTube video thumbnail: Spain ‘More Convinced of Its Own Position’ on the US Than the EU Is, Jaume Duch Tells Euronews
Play
Spain ‘More Convinced of Its Own Position’ on the US Than the EU Is, Jaume Duch Tells Euronews

Video Title

Sign up for:

Health Watch Italy

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.

Explore More

Share us

on your social networks:

Sign up for:

Health Watch Italy

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.